RMTI Rockwell Medical Inc.

2.38
-0.02  -1%
Previous Close 2.4
Open 2.41
Price To Book 5.17
Market Cap 151,902,510
Shares 63,824,584
Volume 299,115
Short Ratio
Av. Daily Volume 533,320

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved January 26, 2015.
Soluble Ferric Pyrophosphate
Anemia
PDUFA date March 28, 2020.
IV Triferic
Anemia

Latest News

  1. Rockwell Medical (RMTI) Q2 2019 Earnings Call Transcript
  2. Edited Transcript of RMTI earnings conference call or presentation 8-Aug-19 8:30pm GMT
  3. Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
  4. Rockwell Medical, Inc. Reports Second Quarter 2019 Financial Results
  5. Rockwell Medical, Inc. Announces Completion of Two Clinical Pharmacology Studies of TRIFERIC® in China
  6. FDA Accepts Rockwell Medical's New Drug Application
  7. Rockwell Medical, Inc. Announces Acceptance by FDA of New Drug Application for I.V. TRIFERIC®
  8. Analysts Estimate Rockwell Medical (RMTI) to Report a Decline in Earnings: What to Look Out for
  9. Why I Like Rockwell Medical, Inc. (NASDAQ:RMTI)
  10. Rockwell Medical, Inc. to Discuss Second Quarter 2019 Financial Results on August 8, 2019
  11. Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Rockwell Medical, Amneal Pharmaceuticals and Intuit and Encourages Investors to Contact the Firm
  12. Rockwell Medical, Inc. (NASDAQ:RMTI): When Will It Breakeven?
  13. Do Insiders Own Shares In Rockwell Medical, Inc. (NASDAQ:RMTI)?
  14. Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Rockwell Medical, Amneal Pharmaceuticals, Kraft Heinz, and Intuit and Encourages Investors to Contact the Firm
  15. Rockwell Medical Announces Pricing of $17.5 Million Public Offering of Common Stock
  16. The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale
  17. Rockwell Medical Announces Proposed Public Offering of Common Stock
  18. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Rockwell Medical, Inc. - RMTI
  19. Rockwell Medical Announces Adjournment of Annual Meeting of Shareholders
  20. Rockwell Medical, Inc. Announces Submission of New Drug Application for I.V. Triferic®